Yes, in most cases you can take a GLP-1 medicine if you have hypothyroidism or Hashimoto's thyroiditis. These common conditions are not contraindications, according to UT Southwestern Medical Center. The thyroid conditions that do rule out some GLP-1s are rarer ones, and your levothyroxine dose and thyroid labs may need closer attention once weight starts to change. This guide explains what is known, what is still uncertain, and what to bring to your clinician. It is general education, not medical advice, and treatment decisions belong to you and a qualified clinician.
TL;DR
- Hypothyroidism and Hashimoto's are not contraindications to GLP-1 medicines. A personal or family history of medullary thyroid cancer (MTC) or MEN2 is a different matter.
- Some GLP-1s may change how oral medicines like levothyroxine are absorbed, and weight loss can change how much thyroid hormone you need.
- In one large study, people with hypothyroidism who lost weight on a GLP-1 saw their TSH fall on average.
- Ask your clinician when to recheck TSH, and never change your levothyroxine dose on your own.
- Approved, compounded and investigational products are not the same thing. Ask which one you are being offered.
Table of Contents
- Is hypothyroidism a reason to avoid GLP-1s?
- The thyroid conditions that do matter: MTC and MEN2
- How GLP-1s can interact with levothyroxine
- What the TSH studies show
- Monitoring: what to ask your clinician
- Semaglutide, liraglutide and tirzepatide: what differs
- Approved, compounded and investigational: know which you are being offered
- How to prepare for your consultation
- Our perspective
- Talk to a clinician about your thyroid and weight goals
- FAQ
- Sources
Is hypothyroidism a reason to avoid GLP-1s?
No. Hypothyroidism, including the autoimmune form called Hashimoto's thyroiditis, is not a contraindication to GLP-1 therapy, per UT Southwestern's patient guidance. The same source says people with other thyroid conditions should tell their doctor and weigh their medical history, expected benefit, other medications and possible side effects before deciding.
The British Thyroid Foundation, a professional body, takes a similar practical line. Its FAQ on weight loss injections and thyroid conditions notes that people taking antithyroid medicines such as carbimazole or propylthiouracil may need additional monitoring, and that they should tell their endocrinologist and GP about weight-loss injections. That page is written for the UK, so US readers should treat it as a general illustration and follow their own clinician's plan.
Two things are worth separating early:
- Safety to start. Having an underactive thyroid does not on its own block treatment.
- Management while on treatment. Your thyroid care is not set and forget. It may need a second look as weight changes and as your dose goes up.
The thyroid conditions that do matter: MTC and MEN2
The label warnings about the thyroid concern a specific, rare cancer, not an underactive gland. The FDA-approved label for Ozempic (semaglutide) lists a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN2) as a contraindication. The prescribing information explains that rodent studies found thyroid C-cell tumors that depended on dose and duration, and that whether this applies to humans is undetermined.
Why does this not extend to hypothyroidism? MTC arises from the thyroid's C-cells. Most other thyroid cancers, and the cells that make thyroid hormone, come from follicular cells. UT Southwestern draws this same distinction and says people with a personal or family history of MTC or MEN2 should not take GLP-1 medications.
Human data on thyroid cancer are mixed. A 2025 review of cohort evidence described one six-cohort study that found no increased thyroid cancer risk compared with DPP-4 inhibitors, but a higher risk compared with sulfonylureas. The honest summary is that the picture is not settled, which is one reason your clinician will ask about your personal and family history before prescribing.
The same label also addresses monitoring. The FDA states that routine serum calcitonin testing or thyroid ultrasound is of uncertain value for early MTC detection and may lead to unnecessary procedures. If you notice a neck lump, trouble swallowing or persistent hoarseness, tell your clinician promptly rather than waiting for a scheduled visit.
How GLP-1s can interact with levothyroxine
If you take levothyroxine, the practical question is absorption. GLP-1 medicines slow how fast the stomach empties, and levothyroxine is an oral tablet that depends on steady absorption.
- Tirzepatide. Lilly's medical information page says tirzepatide delays gastric emptying and may affect the absorption of oral medicines such as levothyroxine.
- Oral semaglutide. In a drug-interaction trial, giving steady-state oral semaglutide with levothyroxine raised total T4 exposure by 33%, though peak concentration was not significantly affected. That trial studied the oral tablet form, not the weekly injection.
What does this mean for you? Not that you should change anything yourself. It means your prescriber should know you take levothyroxine, and a TSH check after starting or increasing a GLP-1 is a reasonable thing to ask about. Your clinician or pharmacist can tell you how to time your thyroid tablet relative to other medicines and meals. Follow their instructions, not a general rule from the internet.
Weight loss itself can change your needs
Thyroid hormone requirements are partly tied to body weight. That is a general principle in thyroid care, and it is why clinicians sometimes revisit the levothyroxine dose after substantial weight loss. Whether and when that applies to you depends on your labs and symptoms, so the decision belongs with your prescriber.
What the TSH studies show
Researchers have started looking at thyroid labs in people on GLP-1s, and early findings are encouraging but observational.
Large health-record study. A study from Epic Research covering 21,538 patients with hypothyroidism found that those who lost more than five pounds after starting a GLP-1 had average TSH reductions of 0.36 to 0.55 mU/L. A lower TSH in someone on levothyroxine can mean the current dose is now relatively higher for their body, which is exactly why timing a recheck matters.
Tirzepatide and levothyroxine. A 2023 conference abstract reported that 65% of patients on a stable levothyroxine dose had a TSH decrease within 4 to 8 weeks of starting tirzepatide.
People without thyroid disease. A small retrospective study of 38 adults with obesity and normal thyroid function found modest but statistically significant TSH decreases after one month of tirzepatide, with levels staying within the normal range.
These are associations. They do not prove a GLP-1 changes the thyroid directly, and the studies are small or retrospective in places. A 2025 review in PMC by Mazza suggests GLP-1 medicines may influence autoimmune thyroid disease indirectly, through weight loss, insulin sensitivity, and anti-inflammatory and gut-immune effects, a hypothesis rather than an established mechanism.
There is also a care-gap finding. A 2026 study in the Journal of Clinical Endocrinology & Metabolism found similar TSH testing patterns after GLP-1 and SGLT-2 inhibitor starts, suggesting missed chances for timely, weight-responsive thyroid monitoring. In plain terms: do not assume anyone will schedule the thyroid check for you. Ask.
Monitoring: what to ask your clinician
There is no single national schedule for thyroid labs on a GLP-1. Some clinicians check TSH a few weeks after each dose increase in levothyroxine users, others check at set intervals, and some tie it to symptoms. Instead of memorizing a protocol, bring these questions:
- Should I get a baseline TSH and free T4 before the first dose?
- When should my TSH be rechecked after I start, and after each dose increase?
- If I lose a meaningful amount of weight, will you reassess my levothyroxine dose?
- How should I time my thyroid tablet around my GLP-1 and other medicines?
- Which symptoms should make me call you sooner?
Symptoms worth reporting include new palpitations, tremor, feeling unusually hot, or unexplained fatigue and feeling cold, since they can point in either direction on thyroid dosing. Persistent vomiting or diarrhea can also affect absorption of oral medicines, so mention it. If digestive side effects are a concern, our guides on GLP-1 nausea and GLP-1 diarrhea cover when to call a doctor.
Semaglutide, liraglutide and tirzepatide: what differs
The evidence for thyroid effects is uneven across medicines, and it is easy to over-read it.
| Medicine | What the evidence above shows | Thing to confirm with your clinician |
|---|---|---|
| Semaglutide | FDA label contraindicates use with personal or family history of MTC or MEN2. Oral form raised T4 exposure 33% with levothyroxine in a trial. | Which form you are prescribed, and levothyroxine timing |
| Tirzepatide | Delays gastric emptying and may affect oral medicine absorption. Small studies show TSH falling after starting. | TSH recheck timing and any label thyroid warnings |
| Liraglutide | Included in broader thyroid cancer cohort research, with mixed findings. | Your personal and family history |
The question "which GLP-1 is best if you have thyroid issues?" does not have a research-backed answer for hypothyroidism. No source we reviewed ranks one medicine as safer for an underactive thyroid. Choice usually rests on your goals, other conditions, insurance coverage, side effects and your clinician's judgment. For background on each, see our pages on semaglutide for weight loss and tirzepatide for weight loss, or the broader overview of GLP-1s for weight loss.
Approved, compounded and investigational: know which you are being offered
The studies above used FDA-approved products. A compounded version is a different thing, and facility registration is not the same as FDA approval of the product. If a provider offers a compounded GLP-1, ask what the ingredients are, which pharmacy prepares it, and how it differs from the approved medicine. Our guide on compounded semaglutide safety questions lists what to ask.
Peptides sold for research or general wellness are another category, and many are investigational. Nothing here is a recommendation to self-treat, and we do not give doses or injection instructions for investigational peptides. That matters even more with a thyroid condition, where unmonitored products could muddy your lab results.
How to prepare for your consultation
A good visit is mostly good preparation. Before you meet with a clinician, gather:
- Your thyroid history: diagnosis, how long you have had it, and whether it is Hashimoto's.
- Your current dose: levothyroxine or other thyroid medicine, brand and strength, and when you take it.
- Recent labs: your latest TSH and free T4 with dates, if you have them.
- Family history: any medullary thyroid cancer, MEN2 or endocrine tumors in relatives.
- All other medicines and supplements, including biotin, which can interfere with some thyroid tests, so ask your clinician whether to pause it before blood draws.
- Your goals and past attempts, so the discussion starts from your situation.
A clinician may decide a GLP-1 is not right for you, may want labs first, or may want to coordinate with your endocrinologist. All of those are normal outcomes of a careful consultation.
Our perspective
Most people with an underactive thyroid who ask us about GLP-1s are really asking two things: "Am I allowed?" and "Who will watch my thyroid while my weight changes?" The first has a reassuring general answer. The second is where good care shows.
We think the best way to approach this is to treat the thyroid as part of the plan from day one. That means a clear medical history, baseline labs, a clinician who knows you take levothyroxine, and an agreed time to recheck. A consultation is built for exactly that kind of conversation, and it is a far better starting point than guessing from forums.
We also think you deserve plain language about what is approved and what is not, and no promises about results. Your clinician decides what is appropriate, and we aim to make it easier to reach one with your questions ready.
AirMedFit
Talk to a clinician about your thyroid and weight goals
If you want to discuss a GLP-1 alongside a thyroid condition, AirMedFit lists doctor's consultations on its site. The Doctor's Consultation page describes the telemedicine appointment, and the consultation listings show the options as published: an Async Doctor's Consult at $49 and a Sync Doctor's Consult at $120, each a one-off fee. Confirm current availability, scope and follow-up on the page before you book, and note that a consultation does not guarantee a prescription. Whether any treatment is appropriate is the clinician's decision.
If you want baseline numbers to bring to that visit, home-kit lab panels are listed under medical services: Men's Essential at $129 and Women's Essential at $139. Ask your clinician whether a panel covers the thyroid tests you need, since the listing alone does not tell you that.
FAQ
Can you take a GLP-1 while having hypothyroidism?
Generally yes. Hypothyroidism and Hashimoto's thyroiditis are not contraindications to GLP-1 medicines, according to UT Southwestern. Your clinician will still review your history, other medicines and any family history of MTC or MEN2. Tell them you take levothyroxine so labs can be timed sensibly.
Can I use Ozempic if I have hypothyroidism?
The Ozempic label contraindicates semaglutide for personal or family history of medullary thyroid carcinoma or MEN2, not for hypothyroidism. If you have an underactive thyroid without those histories, a prescriber can consider it. Ask about TSH rechecks as your weight changes.
Will a GLP-1 change my levothyroxine dose?
It might. Tirzepatide can delay gastric emptying and may affect absorption of oral medicines, and weight loss can change thyroid hormone needs. Studies show TSH often falls in people who lose weight. Do not adjust your dose yourself. Your prescriber should decide from your labs.
Do GLP-1 medicines cause hypothyroidism?
The sources we reviewed do not show that GLP-1 medicines cause hypothyroidism. Research on autoimmune thyroid disease is early, and the proposed effects are indirect. If you develop fatigue, feeling cold or other new symptoms, ask for thyroid labs.
Sources
- UT Southwestern Medical Center: GLP-1 medications and thyroid disease
- FDA Ozempic prescribing information (revised 10/2025)
- British Thyroid Foundation: weight loss injections and thyroid conditions
- Thyroid cancer risk with GLP-1 receptor agonists (PMC)
- Lilly Medical: Zepbound and levothyroxine
- Oral semaglutide and levothyroxine drug-interaction trial (PMC)
- Epic Research: weight loss after GLP-1 starts and thyroid levels
- Changes in thyroid function tests with tirzepatide (PMC)
- Association between tirzepatide therapy and thyroid function (Journal of Endocrinology & Metabolism)
- Patterns of TSH testing after GLP-1 RA initiation (JCEM)
Recommended
- GLP-1 Diarrhea: Immediate Steps, Red Flags, and Doctor Options
- Switching GLP-1 Medicines: Product, Timing & Review Questions
- Cut GLP-1 Nausea by a Third with Prescriber Scripts for Patients
- GLP-1 Fatigue: When to Seek Help and What to Record
This article provides general educational information and is not personalized medical advice. A licensed clinician should assess treatment suitability, risks, and options.